Skip to main content

COVID-19 Intranasal Vaccine Study (CIR 355)

Outpatient study enrolling adults 18-50 years old.

The purpose of this study is to test a new COVID-19 vaccine that is given intranasally (as a nasal spray).  We want to see if it is safe and effective in healthy adults.  The study is:

  • one year long

  • up to 3 screening visits

  • 1-2 vaccine visits (~2-3 hours long)

  • 11 follow up visits (30 min-1 hr long)

Screening Dates

Tuesday, November 28, 2023

Screening Location(s)

CIR at Bayview 

301 Building 4th floor

301 Mason Lord Drive

Baltimore, MD 21224

Study Period

 1 year


 up to $2250